Latest News & Features
Americas
Biotechnology company Biogen has agreed a partnership potentially worth $1 billion with gene therapy business AGTC to develop eye treatments. 7 July 2015
Americas
Law firm Foley Hoag has expanded its intellectual property department by hiring two new partners. 7 July 2015
Africa
The Kenyan government has revealed that there has been an increase in counterfeit drugs entering the country, including antibiotics and Viagra. 6 July 2015
Americas
The market value for biosimilars around the world could reach $20 billion by the end this year and that figure could nearly triple by 2020, according to a report. 3 July 2015
Americas
At a Thomson Reuters event in Paris on Thursday to celebrate the European companies featured on its list of top 100 global innovators, panellists including Novartis and Philips discussed the nature of innovation and how to encourage it. 3 July 2015
Big Pharma
After the English High Court yesterday heard the second day’s arguments in the dispute between Actavis and Warner-Lambert concerning second medical use patents, two lawyers have told LSIPR that similar cases may be on the horizon. 1 July 2015
Americas
The global market for products seeking to tackle counterfeit pharmaceutical and cosmetics packaging will reach more than $80 billion by 2020, according to a report. 30 June 2015
Americas
Jazz Pharmaceuticals has sued Watson Laboratories for patent infringement in order to stop the company making a generic version of its flagship product Xyrem. 30 June 2015
Americas
The US Court of Appeals for the Third Circuit has ruled that so-called ‘pay-for-delay’ settlements do not need to involve cash payments to be considered anticompetitive. 29 June 2015
Americas
The English Court of Appeal has ruled in favour of Eli Lilly, finding that a patent covering its blockbuster lung drug Alimta would be infringed by a product proposed by Actavis, now Allergan. 29 June 2015